BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7438412)

  • 1. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT
    Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
    Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
    Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.
    Awan NA; Needham KE; Evenson MK; Mason DT
    Am J Cardiol; 1981 Mar; 47(3):665-9. PubMed ID: 7468500
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure.
    Elkayam U; Weber L; Torkan B; Berman D; Rahimtoola SH
    Am J Cardiol; 1983 Nov; 52(8):1041-5. PubMed ID: 6637820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hemodynamic actions of prenalterol in left ventricular failure.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
    Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
    Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
    Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
    Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Win A; Mason DT
    Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
    Awan NA; Needham KE; Evenson MK; Win A; Mason DT
    Am Heart J; 1981 Feb; 101(2):158-61. PubMed ID: 7468416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
    Uretsky BF; Seecof RM; Reddy PS
    Can J Cardiol; 1986; 2(2):80-5. PubMed ID: 3085906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute hemodynamic effects of alifedrine in patients with heart failure].
    Schanzenbächer P; Riegger G; Liebau G; Hockerts T; Kochsiek K
    Z Kardiol; 1984 Feb; 73(2):95-100. PubMed ID: 6719988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
    Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
    Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease.
    Cohn K; Selzer A; Kersh ES; Karpman LS; Goldschlager N
    Am J Cardiol; 1975 Apr; 35(4):461-8. PubMed ID: 1119395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of severe chronic CHF with oral pirbuterol.
    Awan NA; Needham K; Evenson MK; Mason DT
    Acta Med Scand Suppl; 1981; 652():155-62. PubMed ID: 6949462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.